Arzneimittel mit denosumab · EU

• Acvybra
  denosumab
  EMEA/H/C/006734
  Reddy Holding GmbH
• Bildyos
  denosumab
  EMEA/H/C/006434
  Sciencepharma Sp. z o.o
• Bilprevda
  denosumab
  EMEA/H/C/006435
  Sciencepharma Sp. z o.o
• Bomyntra
  denosumab
  EMEA/H/C/006269
  Fresenius Kabi Deutschland GmbH
• Conexxence
  denosumab
  EMEA/H/C/006268
  Fresenius Kabi Deutschland GmbH
• Degevma
  denosumab
  EMEA/H/C/006239
  Teva GmbH
• Denbrayce
  denosumab
  EMEA/H/C/006199
  Mabxience Research SL
• Denosumab Ascend
  denosumab
  EMEA/H/C/006626
  Ascend GmbH
• Enwylma
  denosumab
  EMEA/H/C/006376
  Zentiva k.s.
• Evfraxy
  denosumab
  EMEA/H/C/006526
  Biosimilar Collaborations Ireland Limited
• Izamby
  denosumab
  EMEA/H/C/006152
  Mabxience Research SL
• Jubbonti
  denosumab
  EMEA/H/C/005964
  Sandoz GmbH
• Jubereq
  denosumab
  EMEA/H/C/006398
  Accord Healthcare S.L.U.
• Junod
  denosumab
  EMEA/H/C/006436
  Gedeon Richter Plc.
• Kefdensis
  denosumab
  EMEA/H/C/006490
  Stada Arzneimittel AG
• Obodence
  denosumab
  EMEA/H/C/006424
  Samsung Bioepis NL B.V.
• Osenvelt
  denosumab
  EMEA/H/C/006157
  Celltrion Healthcare Hungary Kft.
• Osqay
  denosumab
  EMEA/H/C/006492
  Theramex Ireland Limited
• Osvyrti
  denosumab
  EMEA/H/C/006399
  Accord Healthcare S.L.U.
• Ponlimsi
  denosumab
  EMEA/H/C/006238
  Teva GmbH
• Prolia
  denosumab
  EMEA/H/C/001120
  Amgen Europe B.V.
• Rolcya
  denosumab
  EMEA/H/C/006507
  Sandoz GmbH
• Stoboclo
  denosumab
  EMEA/H/C/006156
  Celltrion Healthcare Hungary Kft.
• Vevzuo
  denosumab
  EMEA/H/C/006534
  Biosimilar Collaborations Ireland Limited
• Vysribli (previously Denosumab Intas)
  denosumab
  EMEA/H/C/006797
  Intas Third Party Sales 2005 S.L.
• Wyost
  denosumab
  EMEA/H/C/006378
  Sandoz GmbH
• Xbonzy
  denosumab
  EMEA/H/C/006722
  Reddy Holding GmbH
• Xbryk
  denosumab
  EMEA/H/C/006468
  Samsung Bioepis NL B.V.
• Xgeva
  denosumab
  EMEA/H/C/002173
  Amgen Europe B.V.
• Yaxwer
  denosumab
  EMEA/H/C/006437
  Gedeon Richter Plc.
• Zadenvi
  denosumab
  EMEA/H/C/006377
  Zentiva k.s.
• Zvogra
  denosumab
  EMEA/H/C/006552
  Stada Arzneimittel AG